Skip to content

Dolutegravir

Dolutegravir (Tivicay) is an integrase inhibitor used with other HIV medicines to reduce the amount of virus in the blood. This listing includes Tivicay and Viropil tablets for HIV-1 infection.

Tivicay

Human Immunodeficiency Virus 1 (HIV-1) Infection

50mg

Dolutegravir tablets for HIV-1 infection. It blocks an enzyme the virus needs to copy itself into cells.

From$8.18/ tabletView

Viropil

Human Immunodeficiency Virus 1 (HIV-1) Infection

50mg + 300mg + 300mg

Dolutegravir and lamivudine tablets for HIV-1 infection. It blocks two different steps in the HIV lifecycle.

From$8.88/ tabletView

Key points

  • Tivicay contains dolutegravir as its only active ingredient.
  • Viropil combines dolutegravir with lamivudine and tenofovir disoproxil in one tablet.
  • Products containing aluminium, magnesium, calcium or iron can affect when dolutegravir should be taken.

How dolutegravir works

Dolutegravir blocks HIV integrase, an enzyme HIV needs to make more copies of itself. Tivicay and Viropil are listed in HIV Management, but Viropil contains two additional HIV medicines alongside dolutegravir.

Further reading